BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6176043)

  • 1. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of proteases and their inhibitors in the pathogenesis of pancreatitis].
    Takasugi S; Kanao M; Nishiki M; Dohi K; Ezaki H
    Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1245-8. PubMed ID: 2418345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An elastase-dependent pathway of plasminogen activation.
    Machovich R; Owen WG
    Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower molecular weight species of alpha 2-macroglobulin-plasmin complexes in human plasma activated by urokinase.
    Yamamoto J; Okamoto U
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1090-9. PubMed ID: 2414954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
    Collen D
    Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in fibrinolytic mechanism].
    Yasukouchi T
    Rinsho Byori; 1986 Mar; 34(3):235-46. PubMed ID: 3086600
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis.
    Moir E; Robbie LA; Bennett B; Booth NA
    Thromb Haemost; 2002 Jun; 87(6):1006-10. PubMed ID: 12083479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.
    Korninger C; Collen D
    Thromb Haemost; 1981 Oct; 46(3):662-5. PubMed ID: 6171907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inhibitors in fibrinolysis.
    Gallimore MJ
    Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of endogenous fibrinolysis activation on human plasminogen].
    Platonova TK; Kalashnikov VV; Khvatov VB
    Biull Eksp Biol Med; 1987 Jan; 103(1):59-61. PubMed ID: 2432967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.